The abstract is read at the publisher; the summary is JClub's.
In 532 CAD patients, 851 plasma proteins are linked to cross-tissue gene regulatory network activity, including networks implicated in CMD and CAD development.
- Why it matters: Plasma biomarkers for CMD and CAD are promising, but without knowing their tissue origins their biological relevance and therapeutic targeting remain unclear.
- What they did: Using multi-omic integration in STARNET, the study profiled 974 plasma proteins and combined them with RNA-seq from arterial wall and major metabolic organs, mapping 262 proteins to source organs and identifying 144 cis-pQTLs.
- The result: The cross-tissue GRN associations indicate plasma proteins function as integral components of these regulatory programs, supporting more reliable diagnostics and more precise therapeutic targets.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.